TY - JOUR
T1 - Effect of confounding cofactors on responses to pollens during natural season versus pollen challenge chamber exposure
AU - Jacobs, Robert L.
AU - Harper, Nathan
AU - He, Weijing
AU - Andrews, Charles P.
AU - Rather, Cynthia G.
AU - Ramirez, Daniel A.
AU - Ahuja, Sunil K.
N1 - Funding Information:
S.K.A. received support from the following sources: the Doris Duke Distinguished Clinical Scientist Award , the Burroughs Wellcome Clinical Scientist in Translational Research Award , the Max and Minnie Tomerlin Voelcker Scholar Award , and the Center for Personalized Medicine at the South Texas Veterans Health Care System .
PY - 2014/5
Y1 - 2014/5
N2 - Background The severity of allergic rhinoconjunctivitis (AR) symptomatology elicited after exposure to pollen in the absence versus the presence of confounding cofactors, such as in a pollen challenge chamber (PCC) and the natural pollinating season, respectively, might differ. Objective We sought to determine the correlation of AR severity in the natural season versus out-of-season PCC exposures. Methods Twenty-four Virginia live oak (VLO)-positive, 14 VLO-negative, 16 mountain cedar (MC)-positive, 8 MC-negative, and 26 ragweed-positive participants recorded AR symptoms (total symptom score [TSS]) during the VLO, MC, and ragweed pollinating seasons and during 2 consecutive PCC exposures of 3 hours each to these pollens separately. Results The TSSs recorded before the natural season were higher than the pre-PCC values. This prepriming was greater among VLO+ than MC+ participants, and it blunted further increases in TSSs during the VLO natural season. Nonatopic participants were nonreactive in the PCC. There was wide variation in the level of AR symptomatology after exposure to VLO, MC, or ragweed pollen in the PCC. Prepriming formed the basis for higher AR responses observed in the natural season than in the PCC, resulting in the identification of distinct PCC/natural season endophenotypes and a partial correlation between the TSSs recorded in the natural season versus those recorded in the PCC (r = 0.34, 0.54, and 0.65 for VLO+, MC+, and ragweed-positive participants, respectively). Conclusions Prepriming in the natural pollinating season might obscure the true correlation between AR severity in the natural season versus the PCC. By mitigating confounding cofactors, PCC exposures have utility for evaluation of novel AR therapeutics.
AB - Background The severity of allergic rhinoconjunctivitis (AR) symptomatology elicited after exposure to pollen in the absence versus the presence of confounding cofactors, such as in a pollen challenge chamber (PCC) and the natural pollinating season, respectively, might differ. Objective We sought to determine the correlation of AR severity in the natural season versus out-of-season PCC exposures. Methods Twenty-four Virginia live oak (VLO)-positive, 14 VLO-negative, 16 mountain cedar (MC)-positive, 8 MC-negative, and 26 ragweed-positive participants recorded AR symptoms (total symptom score [TSS]) during the VLO, MC, and ragweed pollinating seasons and during 2 consecutive PCC exposures of 3 hours each to these pollens separately. Results The TSSs recorded before the natural season were higher than the pre-PCC values. This prepriming was greater among VLO+ than MC+ participants, and it blunted further increases in TSSs during the VLO natural season. Nonatopic participants were nonreactive in the PCC. There was wide variation in the level of AR symptomatology after exposure to VLO, MC, or ragweed pollen in the PCC. Prepriming formed the basis for higher AR responses observed in the natural season than in the PCC, resulting in the identification of distinct PCC/natural season endophenotypes and a partial correlation between the TSSs recorded in the natural season versus those recorded in the PCC (r = 0.34, 0.54, and 0.65 for VLO+, MC+, and ragweed-positive participants, respectively). Conclusions Prepriming in the natural pollinating season might obscure the true correlation between AR severity in the natural season versus the PCC. By mitigating confounding cofactors, PCC exposures have utility for evaluation of novel AR therapeutics.
KW - Allergy
KW - challenge
KW - confounding
KW - pollen
KW - season
UR - http://www.scopus.com/inward/record.url?scp=84899618678&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84899618678&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2013.09.051
DO - 10.1016/j.jaci.2013.09.051
M3 - Article
C2 - 24331377
AN - SCOPUS:84899618678
SN - 0091-6749
VL - 133
SP - 1340-1346.e7
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 5
ER -